CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Invesco Currencyshares Swedish Krona Trust  (FXS)
Other Ticker:  
 
    Sector  Financial    Industry Investment Services
   Industry Investment Services
   Sector  Financial
 
Price: $101.3066 $0.25 0.249%
Day's High: $101.46 Week Perf: 0.95 %
Day's Low: $ 101.31 30 Day Perf: 0.54 %
Volume (M): 0 52 Wk High: $ 115.97
Volume (M$): $ 30 52 Wk Avg: $105.52
Open: $101.40 52 Wk Low: $98.54



 Market Capitalization (Millions $) 15
 Shares Outstanding (Millions) 0
 Employees 1
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -0
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Invesco Currencyshares Swedish Krona Trust

The CurrencyShares® Swedish Krona Trust (the “Trust”) is a grantor trust that was formed on June 8, 2006. The Shares commenced trading on the New York Stock Exchange under the ticker symbol “FXS” on June 26, 2006. The primary listing of the Shares was transferred to NYSE Arca Inc. (“NYSE Arca”) on October 30, 2007. The Trust issues shares (the “Shares”) in blocks of 50,000 (a “Basket”) in exchange for deposits of Swedish Kronor and distributes Swedish Kronor in connection with the redemption of Baskets.


The investment objective of the Trust is for the Shares to reflect the price in USD of Swedish Krona plus accrued interest, if any, less the expenses of the Trust’s operations. The Shares are intended to offer investors an opportunity to participate in the market for the Swedish Krona through an investment in securities. The Shares are intended to provide institutional and retail investors with a simple, cost-effective means of gaining investment benefits similar to those of holding the Swedish Krona. The Shares are bought and sold on NYSE Arca like any other exchange-listed security. The Shares are backed by the assets of the Trust, which does not hold or use derivative products. The Trust is a passive investment vehicle and does not have any officers, directors or employees. The Trust does not engage in any activities designed to obtain profit from, or ameliorate losses caused by, changes in the price of the Swedish Krona. Investing in the Shares does not insulate the investor from certain risks, including price volatility. The value of the holdings of the Trust is reported on the Trust’s website, www.currencyshares.com, each business day.



 

Adesto Technologies Corp

Deficit Bigger Than a Year Ago, Sales very Strong

In the forth quarter Adesto Technologies Corp losses widen of $-0.23 per share compare to $-0.01 a year ago and improved from $-0.29 per share from the previous quarter.

Sales grew strongly by 73.81 % to $28.08 millions from $16.15 millions in the same quarter a year ago and sequentially Sales improved by 28.05 % from $21.93 millions.

Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc announced forth quarter operating loss of $-2.547251 millions

In the forth quarter Ampio Pharmaceuticals, Inc earnings turn positive of $0.06 per share compare to $-0.57 a year ago and eps decreased by -6.74 % from $0.06 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Wayside Technology Group, Inc.

Outstanding EPS Increase but Revenues Sink

In the forth quarter Wayside Technology Group, Inc earnings jumped by 50.24 % of $0.40 per share compare to $0.26 a year ago and earnings grew by 36.25 % from $0.29 per share from the previous quarter.

Sales fell sharply by -61.36 % to $49.06 millions from $126.96 millions in the same quarter a year ago and sequentially Sales increased by 2.36 % from $47.92 millions.

Bcb Bancorp Inc

Bcb Bancorp Inc announced forth quarter operating surplus of $7.625 millions

Bcb Bancorp Inc showed respectable growth in the forth quarter, where earnings per share soared by 301.82 % year on year to $0.31 per share and Revenue increased by 20.62 % to $21.51 millions.

Arcturus Therapeutics Ltd.

Deficit Bigger Than a Year Ago but Revenues Unchanged

In the forth quarter Arcturus Therapeutics Ltd losses widen of $-0.38 per share compare to $0.00 a year ago and improved from $-0.42 per share from the previous quarter.

Sales remained unchanged to $9.94 millions from $0.00 millions in the same quarter a year ago and sequentially Sales doubled by 190.51 % from $3.42 millions.






Customers Net Income grew by FXS's customers Net margin grew to
512.71 % 19.83 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


You need to upgrade your Flash Player

   
Major Competitors Stock performance

5 Days Decrease / Increase
     
FPF        0.05% 
VIXY   -3.46%    
UDN        0.58% 
FXC        0.39% 
FXB        1.49% 
FXA        0.14% 
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KDMN's Profile

Stock Price

KDMN's Financials

Business Description

Fundamentals

Charts & Quotes

KDMN's News

Suppliers

KDMN's Competitors

Customers & Markets

Economic Indicators

KDMN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071